Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Bladder Cancer

  Free Subscription


05.02.2024

1 Adv Ther
1 Am J Clin Pathol
1 Ann Noninvasive Electrocardiol
1 Anticancer Res
1 Arch Pathol Lab Med
2 Asian J Surg
1 Biochim Biophys Acta Mol Cell Res
1 Biomater Adv
1 BJU Int
2 BMC Cancer
1 BMC Med Imaging
1 BMC Urol
1 Cancer Biomark
1 Carcinogenesis
1 Cell Mol Biol (Noisy-le-grand)
1 Cytotechnology
1 Drug Resist Updat
1 Emerg Med Int
1 Environ Toxicol
1 Eur Heart J Cardiovasc Imaging
1 Eur Urol
2 Eur Urol Focus
2 Eur Urol Oncol
1 Eur Urol Open Sci
3 Front Immunol
1 Front Oncol
1 Front Pharmacol
1 Heliyon
2 Int J Mol Sci
1 Int J Pharm
1 Int J Rheum Dis
1 iScience
1 J Cancer Surviv
1 J Control Release
1 J Endourol
1 J Extracell Vesicles
3 J Gene Med
1 J Mol Diagn
1 J Urol
1 JCO Glob Oncol
1 JNMA J Nepal Med Assoc
1 Nan Fang Yi Ke Da Xue Xue Bao
1 Nat Rev Clin Oncol
1 Nat Rev Urol
1 Nucleosides Nucleotides Nucleic Acids
1 Phys Med Biol
1 PLoS One
4 Sci Rep
1 Toxicol Res (Camb)
2 Urol Oncol
1 Urol Pract
1 Urology
1 Zhonghua Bing Li Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Adv Ther

  1. BLACK PC, Eigl BJ
    The Evolving Role of PD-(L)1 Inhibition in Optimizing Outcomes for High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC): A Podcast.
    Adv Ther. 2024 Feb 2. doi: 10.1007/s12325-023-02763.
    PubMed        


    Am J Clin Pathol

  2. WEI W, Wu D, Zhang Z, Liu J, et al
    Comparison of DNA methylation and cytology tests in urine to detect upper tract urothelial carcinoma: A paired-design diagnostic study.
    Am J Clin Pathol. 2024;161:115-121.
    PubMed         Abstract available


    Ann Noninvasive Electrocardiol

  3. CHEN ZL, Jia KP, Zheng Y, Zhang N, et al
    Electrocardiographic characteristics of bladder cancer patients receiving preoperative chemotherapy combined with immunotherapy.
    Ann Noninvasive Electrocardiol. 2024;29:e13107.
    PubMed         Abstract available


    Anticancer Res

  4. ONER M, Lin E, Chiu KY, Chen MC, et al
    p35/CDK5 Regulates Bladder Cancer Proliferation and Migration and Promotes Higher Tumor Grade and Poor Survival Rate in Patients With Bladder Cancer.
    Anticancer Res. 2024;44:543-553.
    PubMed         Abstract available


    Arch Pathol Lab Med

  5. OLIVER-KRASINSKI JM, Bidot S, Ingram JW, O'Toole KM, et al
    Noninvasive Papillary Urothelial Carcinoma of the Bladder: An Institutional Experience Focusing on Tumors With Borderline Features.
    Arch Pathol Lab Med. 2024;148:223-229.
    PubMed         Abstract available


    Asian J Surg

  6. LV HX, Wang D, Zhou FH
    Definition of the prognosis value of urine extracellular vesicles ZNF540 in bladder cancer based on GEO database.
    Asian J Surg. 2024 Jan 30:S1015-9584(24)00109.
    PubMed        

  7. MAO Q, Liu H, Wu J, Cui Y, et al
    Prognostic significance of lncRNA AL354919.2 in bladder cancer.
    Asian J Surg. 2024 Jan 25:S1015-9584(24)00099.
    PubMed        


    Biochim Biophys Acta Mol Cell Res

  8. ZHU C, Fang X, Liu X, Jiang C, et al
    Squalene monooxygenase facilitates bladder cancer development in part by regulating PCNA.
    Biochim Biophys Acta Mol Cell Res. 2024;1871:119681.
    PubMed         Abstract available


    Biomater Adv

  9. LIU Y, Qi P, Chen G, Lang Z, et al
    Nanoreactor based on single-atom nanoenzymes promotes ferroptosis for cancer immunotherapy.
    Biomater Adv. 2024;157:213758.
    PubMed         Abstract available


    BJU Int

  10. LU SM, Zhang Y, Dong XT, Wang JL, et al
    Microchip for detection of cell-free DNA in urine to help identify patients with bladder cancer.
    BJU Int. 2024 Jan 30. doi: 10.1111/bju.16271.
    PubMed        


    BMC Cancer

  11. PAN DL, Zhang LF, Li XJ, Zhang KP, et al
    Feasibility and safety of laparoscopic radical cystectomy for male octogenarians with muscle-invasive bladder cancer.
    BMC Cancer. 2024;24:159.
    PubMed         Abstract available

  12. VERGHOTE F, Van Praet C, Berquin C, Lumen N, et al
    Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer: a qualitative study exploring patient priorities and counselling needs when making a treatment choice.
    BMC Cancer. 2024;24:160.
    PubMed         Abstract available


    BMC Med Imaging

  13. ZHANG HP, Liang RX, Lin XY, Xue ES, et al
    Application of contrast-enhanced ultrasound in diagnosis and grading of bladder urothelial carcinoma.
    BMC Med Imaging. 2024;24:26.
    PubMed         Abstract available


    BMC Urol

  14. CHEN S, Sun G, Chen X, Salgado T, et al
    Is switching intravesical chemotherapeutic agents beneficial in short-term recurrent high-risk non-muscle-invasive bladder tumors? A 5-year retrospective study.
    BMC Urol. 2024;24:25.
    PubMed         Abstract available


    Cancer Biomark

  15. ZHAO ZY, Cao Y, Wang HL, Liu LY, et al
    A risk model based on lncRNA-miRNA-mRNA gene signature for predicting prognosis of patients with bladder cancer.
    Cancer Biomark. 2024 Jan 8. doi: 10.3233/CBM-230216.
    PubMed         Abstract available


    Carcinogenesis

  16. PAN J, Xie X, Sheng J, Ju C, et al
    Construction and identification of lncRNA/circRNA-coregulated ceRNA networks in gemcitabine-resistant bladder carcinoma.
    Carcinogenesis. 2023;44:847-858.
    PubMed         Abstract available


    Cell Mol Biol (Noisy-le-grand)

  17. SU Y, Chen H, Yao L, Dai H, et al
    The relationship between the expression of lncRNA MALAT1 and clinical features and prognosis in bladder cancer: A meta-analysis.
    Cell Mol Biol (Noisy-le-grand). 2023;69:166-171.
    PubMed         Abstract available


    Cytotechnology

  18. YU J, Ge S
    PRPF19 functions in DNA damage repair and gemcitabine sensitivity via regulating DDB1 in bladder cancer cells.
    Cytotechnology. 2024;76:85-96.
    PubMed         Abstract available


    Drug Resist Updat

  19. LI F, Zhang H, Huang Y, Li D, et al
    Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer.
    Drug Resist Updat. 2024;73:101059.
    PubMed         Abstract available


    Emerg Med Int

  20. INTERNATIONAL EM
    Retracted: Preoperative Nutritional Risk Assessment for Predicting Complications after Radical Cystectomy plus Urinary Diversion for Bladder Cancer.
    Emerg Med Int. 2024;2024:9849523.
    PubMed         Abstract available


    Environ Toxicol

  21. LI P, Wang W, Zhu B, Wang Y, et al
    PRDX2 regulates stemness contributing to cisplatin resistance and metastasis in bladder cancer.
    Environ Toxicol. 2024 Jan 31. doi: 10.1002/tox.24153.
    PubMed         Abstract available


    Eur Heart J Cardiovasc Imaging

  22. RICCHETTI G, Grimaldi A, Agricola E, Slavich M, et al
    Cardiac metastasis from urothelial carcinoma: a stealthy precursor.
    Eur Heart J Cardiovasc Imaging. 2024;25:e92.
    PubMed        


    Eur Urol

  23. BINHUMAID FS, Goel A, Gordon NS, Abbotts B, et al
    Circulating Tumour Dna Detection By The Urine-Informed Analysis Of Archival Serum Samples From Muscle-Invasive Bladder Cancer Patients.
    Eur Urol. 2024 Jan 31:S0302-2838(24)00017-4. doi: 10.1016/j.eururo.2024.
    PubMed        


    Eur Urol Focus

  24. SORIA F, Gontero P
    Reply to Marco Moschini, Francesco Montorsi, Andrea Salonia, Giorgio Gandaglia and Alberto Briganti's Letter to the Editor Re: Francesco Soria, Matteo Rosazza, Simone Livoti, et al. Repeat Transurethral Resection (TUR) + Bacillus Calmette-Guerin (BCG)
    Eur Urol Focus. 2024 Jan 25:S2405-4569(24)00004.
    PubMed        

  25. LIN YH, Tsai HY, Juang HH
    Re: Christopher D. Gaffney, Andrew Katims, Neeta D'Souza, Marc A. Bjurlin, Richard S. Matulewicz. Bladder Cancer Carcinogens: Opportunities for Risk Reduction. Eur Urol Focus 2023;9:575-8.
    Eur Urol Focus. 2024 Jan 25:S2405-4569(24)00006.
    PubMed        


    Eur Urol Oncol

  26. MARIAPPAN P, Johnston A, Trail M, Hamid S, et al
    Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression in Non-muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2024 Jan 30:S2588-9311(24)00037.
    PubMed         Abstract available

  27. LOBO N, Duan Z, Sood A, Tan WS, et al
    Association of Age with Non-muscle-invasive Bladder Cancer: Unearthing a Biological Basis for Epidemiological Disparities?
    Eur Urol Oncol. 2024 Jan 31:S2588-9311(24)00036.
    PubMed         Abstract available


    Eur Urol Open Sci

  28. NARDELLI C, Aveta A, Pandolfo SD, Tripodi L, et al
    Microbiome Profiling in Bladder Cancer Patients Using the First-morning Urine Sample.
    Eur Urol Open Sci. 2023;59:18-26.
    PubMed         Abstract available


    Front Immunol

  29. YANG H, Ma L, Deng W, Fu B, et al
    Prognostic biomarker DARS2 correlated with immune infiltrates in bladder tumor.
    Front Immunol. 2024;14:1301945.
    PubMed         Abstract available

  30. XU Y, Sun X, Liu G, Li H, et al
    Integration of multi-omics and clinical treatment data reveals bladder cancer therapeutic vulnerability gene combinations and prognostic risks.
    Front Immunol. 2024;14:1301157.
    PubMed         Abstract available

  31. SCHNEIDER AK, Domingos-Pereira S, Cesson V, Polak L, et al
    Type 2 innate lymphoid cells are not involved in mouse bladder tumor development.
    Front Immunol. 2024;14:1335326.
    PubMed         Abstract available


    Front Oncol

  32. MONSHAUGEN I, Luna L, Rhodes J, Kristiansen FIS, et al
    Depletion of the m1A writer TRMT6/TRMT61A reduces proliferation and resistance against cellular stress in bladder cancer.
    Front Oncol. 2024;13:1334112.
    PubMed         Abstract available


    Front Pharmacol

  33. ZHU S, Zhao H
    Sexual dimorphism in bladder cancer: a review of etiology, biology, diagnosis, and outcomes.
    Front Pharmacol. 2024;14:1326627.
    PubMed         Abstract available


    Heliyon

  34. WEI Z, Liu H, Xv Y, Liao F, et al
    Development and validation of a CT-based deep learning radiomics nomogram to predict muscle invasion in bladder cancer.
    Heliyon. 2024;10:e24878.
    PubMed         Abstract available


    Int J Mol Sci

  35. JO A, Joh HM, Bae JH, Kim SJ, et al
    Plasma-Activated Media Produced by a Microwave-Excited Atmospheric Pressure Plasma Jet Is Effective against Cisplatin-Resistant Human Bladder Cancer Cells In Vitro.
    Int J Mol Sci. 2024;25:1249.
    PubMed         Abstract available

  36. LUMKUL L, Jantaree P, Jaisamak K, Wongkummool W, et al
    Combinatorial Gene Expression Profiling of Serum HULC, HOTAIR, and UCA1 lncRNAs to Differentiate Hepatocellular Carcinoma from Liver Diseases: A Systematic Review and Meta-Analysis.
    Int J Mol Sci. 2024;25:1258.
    PubMed         Abstract available


    Int J Pharm

  37. REN Y, Liu T, Li S, Ma X, et al
    An iodine?labelled Antibody-drug conjugate PET probe for noninvasive monitoring of Nectin-4 expression in urothelial carcinoma.
    Int J Pharm. 2024;651:123756.
    PubMed         Abstract available


    Int J Rheum Dis

  38. BANDEIRA M, Dourado E, Lopes F, Tenazinha C, et al
    Reactive arthritis as a rare complication of intravesical bacillus Calmette-Guerin treatment: Report of two cases.
    Int J Rheum Dis. 2024;27:e14862.
    PubMed         Abstract available


    iScience

  39. WANG J, Tan J, Zhang Y, Zhou L, et al
    circCD2AP promotes epithelial mesenchymal transition and stemness in bladder cancer by regulating FOXQ1/USP21 axis.
    iScience. 2023;27:108447.
    PubMed         Abstract available


    J Cancer Surviv

  40. BAHLBURG H, Reicherz A, Reike M, Bach P, et al
    A prospective evaluation of quality of life, psychosocial distress, and functional outcomes two years after radical cystectomy and urinary diversion in 842 German bladder cancer patients.
    J Cancer Surviv. 2024 Jan 30. doi: 10.1007/s11764-024-01535.
    PubMed         Abstract available


    J Control Release

  41. SUN Y, Lu Z, Taylor JA, Au JLS, et al
    Quantitative image analysis of intracellular protein translocation in 3-dimensional tissues for pharmacodynamic studies of immunogenic cell death.
    J Control Release. 2024;365:89-100.
    PubMed         Abstract available


    J Endourol

  42. BAUST JM, Corcoran A, Robilotto A, Katz AE, et al
    Evaluation of a New Cystoscopic Cryocatheter and Method for the In Situ Destruction of Bladder Cancer: Preliminary In vivo Study.
    J Endourol. 2024 Jan 27. doi: 10.1089/end.2023.0635.
    PubMed         Abstract available


    J Extracell Vesicles

  43. DONG L, Feng M, Kuczler MD, Horie K, et al
    Tumour tissue-derived small extracellular vesicles reflect molecular subtypes of bladder cancer.
    J Extracell Vesicles. 2024;13:e12402.
    PubMed         Abstract available


    J Gene Med

  44. SU H, Liu Z, Zhang C, Deng Z, et al
    Exploration of the prognostic effect of costimulatory genes in bladder cancer.
    J Gene Med. 2024;26:e3655.
    PubMed         Abstract available

  45. JIANG S, Yang X, Lin Y, Liu Y, et al
    Unveiling Anoikis-related genes: A breakthrough in the prognosis of bladder cancer.
    J Gene Med. 2024;26:e3651.
    PubMed         Abstract available

  46. WANG CS, Lee YC, Jhan JH, Li WM, et al
    MicroRNA-299-3p inhibits cell proliferation, motility, invasion and angiogenesis via VEGFA in upper tract urothelial carcinoma.
    J Gene Med. 2024;26:e3616.
    PubMed         Abstract available


    J Mol Diagn

  47. ABE M, Hiraki H, Tsuyukubo T, Ono S, et al
    The clinical validity of urinary pellet DNA monitoring for the diagnosis of recurrent bladder cancer.
    J Mol Diagn. 2024 Jan 30:S1525-1578(24)00012.
    PubMed         Abstract available


    J Urol

  48. KAY H, Matulewicz RS, Bjurlin MA
    Clearing the Smoke: Underreporting of Smoking Status in Food and Drug Administration-Approved Bladder Cancer Therapeutic Trials.
    J Urol. 2024 Feb 1:101097JU0000000000003853. doi: 10.1097/JU.0000000000003853.
    PubMed        


    JCO Glob Oncol

  49. MANNEH KOPP R, Galanternik F, Schutz FA, Kater F, et al
    Latin American Consensus for the Evaluation and Treatment of Patients With Metastatic/Locally Advanced Urothelial Carcinoma.
    JCO Glob Oncol. 2024;10:e2300244.
    PubMed         Abstract available


    JNMA J Nepal Med Assoc

  50. MISHRA P, Jiongming L, Jianhe L, Kewei F, et al
    Prostate Cancer among Patients Undergoing Radical Cystoprostatectomy for Bladder Cancer in the Department of Urology in a Tertiary Care Centre.
    JNMA J Nepal Med Assoc. 2023;61:782-786.
    PubMed         Abstract available


    Nan Fang Yi Ke Da Xue Xue Bao

  51. YAN Q, Zeng P, Huang S, Tan C, et al
    [RBMX overexpression inhibits proliferation, migration, invasion and glycolysis of human bladder cancer cells by downregulating PKM2].
    Nan Fang Yi Ke Da Xue Xue Bao. 2024;44:9-16.
    PubMed         Abstract available


    Nat Rev Clin Oncol

  52. KLEMM J, Laukhtina E, Shariat SF
    Combination neoadjuvant therapies are paving the way for bladder preservation to become the standard for selected patients.
    Nat Rev Clin Oncol. 2024;21:87-88.
    PubMed        


    Nat Rev Urol

  53. GROBET-JEANDIN E, Lenfant L, Pinar U, Parra J, et al
    Management of patients with muscle-invasive bladder cancer with clinical evidence of pelvic lymph node metastases.
    Nat Rev Urol. 2024 Jan 31. doi: 10.1038/s41585-023-00842.
    PubMed         Abstract available


    Nucleosides Nucleotides Nucleic Acids

  54. BOSTANCI E, Kirkik D, Kalkanli Tas S, Uyeturk U, et al
    Genetic insights into bladder cancer: the impact of SIRT1 gene polymorphism.
    Nucleosides Nucleotides Nucleic Acids. 2024.
    PubMed         Abstract available


    Phys Med Biol

  55. YU J, Cai L, Chen C, Zou Y, et al
    A novel predict method for muscular invasion of bladder cancer based on 3D mp-MRI feature fusion.
    Phys Med Biol. 2024 Feb 2. doi: 10.1088/1361-6560.
    PubMed         Abstract available


    PLoS One

  56. KVIKSTAD V, Lillesand M, Gudlaugsson E, Mangrud OM, et al
    Proliferation and immunohistochemistry for p53, CD25 and CK20 in predicting prognosis of non-muscle invasive papillary urothelial carcinomas.
    PLoS One. 2024;19:e0297141.
    PubMed         Abstract available


    Sci Rep

  57. NIE Z, Guo N, Peng Y, Gao Y, et al
    Author Correction: Duality of the SVIL expression in bladder cancer and its correlation with immune infiltration.
    Sci Rep. 2024;14:2369.
    PubMed        

  58. IIDA K, Naiki T, Etani T, Nagai T, et al
    Proton pump inhibitors and potassium competitive acid blockers decrease pembrolizumab efficacy in patients with metastatic urothelial carcinoma.
    Sci Rep. 2024;14:2520.
    PubMed         Abstract available

  59. DEMIR R, Koc S, Ozturk DG, Bilir S, et al
    Artificial intelligence assisted patient blood and urine droplet pattern analysis for non-invasive and accurate diagnosis of bladder cancer.
    Sci Rep. 2024;14:2488.
    PubMed         Abstract available

  60. WANG H, Liu J, Lou Y, Liu Y, et al
    Identification and preliminary analysis of hub genes associated with bladder cancer progression by comprehensive bioinformatics analysis.
    Sci Rep. 2024;14:2782.
    PubMed         Abstract available


    Toxicol Res (Camb)

  61. LIU Z, Du D, Zhang S
    Integrated bioinformatics analysis identifies a Ferroptosis-related gene signature as prognosis model and potential therapeutic target of bladder cancer.
    Toxicol Res (Camb). 2024;13:tfae010.
    PubMed         Abstract available


    Urol Oncol

  62. PORRECA A, Di Nicola M, Lucarelli G, Dorin VM, et al
    Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database.
    Urol Oncol. 2024 Jan 31:S1078-1439(24)00003.
    PubMed         Abstract available

  63. LOTAN Y, Agarwal P, Black P, Dickstein R, et al
    Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trials.
    Urol Oncol. 2024 Feb 1:S1078-1439(24)00020-6. doi: 10.1016/j.urolonc.2024.
    PubMed         Abstract available


    Urol Pract

  64. SEGEL JE, Wong WG, Kaag M, Joshi M, et al
    Relationship Between Availability of Urologists and Primary Care Providers and Stage of Diagnosis for Invasive Urinary Bladder Cancer.
    Urol Pract. 2024 Jan 15:101097UPJ0000000000000503.
    PubMed         Abstract available


    Urology

  65. MORRIS KE, Pappas TN
    Malignancy in the public life: the story of Hubert Humphrey's bladder cancer.
    Urology. 2024 Jan 31:S0090-4295(24)00017-7. doi: 10.1016/j.urology.2023.
    PubMed        


    Zhonghua Bing Li Xue Za Zhi

  66. HUANG WQ, Zhang L, Fu S, Shi GZ, et al
    [Mesonephric-like adenocarcinoma of the female urinary bladder associated with endometriosis: report of a case].
    Zhonghua Bing Li Xue Za Zhi. 2024;53:201-203.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.